FDA Approves Mobius Therapeutics' Glaucoma Drug

The FDA has approved St. Louis-based Mobius Therapeutics' Mitosol product for use in glaucoma surgery, according to a news release.

Mitosol is a system for delivering antifibrotic agents in glaucoma, refractive and corneal surgery, though the refractive and corneal indications are awaiting approval by the FDA.

Related Articles on Ophthalmology:
Pioneering Ophthalmologist Dr. Robert C. Welsh Dies at Age 89
Dr. Alan Faulkner Now Offering LenSx Femtosecond Laser at his Hawaii Cataract Surgery Practice
Dr. Ruth D. Williams Begins Term as President of the American Academy of Ophthalmology

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Articles We Think You'll Like

 

Featured Whitepapers

Featured Webinars